Research Library

The top resource for free research, white papers, reports, case studies, magazines, and eBooks.

Share Your Content with Us
on TradePub.com for readers like you. LEARN MORE
CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry
Request Your Free White Paper Now:

"CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry"

Advanced gene editing technologies can be implemented successfully for the improvement of drug discovery disease models and assay development.

Single-guided RNA CRISPR technologies create unwanted off-target mutations that may derail research investments. Many of these technologies have also been hampered by intellectual property entanglements and restrictive licensing. This article introduces our Cas-CLOVER gene editing technology, which is a dimeric guide system, free of detectable off-targets and licensing impediments “the clean alternative to CRISPR/Cas9”. It is our mission to make this technology readily available in the discovery research space through services and accessible licensing with freedom to operate.


Offered Free by: HeraBiolabs
See All Resources from: HeraBiolabs

Recommended for Professionals Like You: